MeRes100™

Primary DI

18904224914862

Basic UDI-DI Code

B-18904224914862

Reference

MRS25013

Device Types

Single use Sterile

Regulation

Eu Mdd

Classification

Eu Md Class 3

Status

On The Market

Manufacturer

Meril Life Sciences Pvt. Ltd.

The Sirolimus Eluting Bioresorbable Vascular Scaffold System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to de novo lesion in native coronary arteries in patients eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA) and Scaffolding procedures.The scaffold will eventually resorb and potentially facilitate normalization of vessel function in patients. Covering of minimum 2 mm of non-diseased tissue on either side of the target lesion is recommended. For example, the lesion length may not be more than 15 mm for the scaffold with 19 mm length.

Other on-the-market devices with the same classification (Eu Md Class 3) and regulation (EU MDD).